KRMD - candlestick chart analysis of KORU Medical Systems Inc.

Popular stocks today

ADMA AKTS AMC BTG FATE FUBO LAZR NFLX NKE NVDA ORCL PSX SCHH SOXL SPY TMF TSLA UUUU VOO VRT

Membership
- Log In
- Log Out
- Sign Up
- About HotCandlestick
- Benefits
- Help
Candlestick Charts
Chart Education
Trading Tools
Opportunities
External Links

Official PayPal Seal

As Seen In...

The Complete Guide to Using Candlestick Charting: How to Earn High Rates of Return safely

End of day quotes updated Fri Jan 17 15:47 CST
🏠

⎙

🔍

◄ Daily Pattern ► ◄ Weekly Pattern ► ◄ Monthly Pattern ► ◄ Quarterly Pattern ►
Bearish Harami Cross Bullish Stick Sandwich Bullish Engulfing none
17-Jul-2024 19-Jul-2024 30-Nov-2021 unknown
16.4 strength -92.9 strength 189.2 strength

KRMD	SPY
2.2 3.3 6.2 6.2 6.2	1.0 2.9 2.0 2.0 2.0
% Price Gain WTD Performance (%) MTD Performance (%) QTD Performance (%) YTD Performance (%)
SPY tracks S&P 500 index.

KRMD News
14-Jan-2025 3:06 PM CST - Business Wire KORU Medical Systems Reports Preliminary Fourth Quarter and Full Year 2024 Results; Achieves Record Full Year and Quarterly Revenues; Positive Cash Flow for the Fourth Quarter KORU Medical Systems (NASDAQ: KRMD) (KORU Medical or the Company), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and patient-centric large volume subcutaneous infusion solutions, today announced preliminary unaudited results for the fourth quarter and full year ended December 31, 2024. Financial Results (unaudited) Preliminary, unaudited fourth quarter 2024 net revenues expected to be $8.9 m
13-Jan-2025 7:00 AM CST - Business Wire KORU Medical Systems Reports Preliminary Fourth Quarter and Full Year 2024 Results; Achieves Record Full Year and Quarterly Revenues; Positive Cash Flow for the Fourth Quarter KORU Medical Systems (NASDAQ: KRMD) (KORU Medical or the Company), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and patient-centric large volume subcutaneous infusion solutions, today announced preliminary unaudited results for the fourth quarter and full year ended December 31, 2024. Financial Results (unaudited) Preliminary, unaudited fourth quarter 2024 net revenues expected to be $8.9 m
13-Nov-2024 3:05 PM CST - Business Wire KORU Medical Systems, Inc. Announces 2024 Q3 Financial Results, Third Consecutive Quarter of Double-Digit Growth; Raises Full Year 2024 Guidance KORU Medical Systems, Inc. (NASDAQ: KRMD) (KORU Medical or the Company), a leading medical technology company focused on development, manufacturing, and commercialization of innovative and patient-centric large volume subcutaneous infusion solutions, today reported financial results for the third quarter ended September 30, 2024, and raised full year 2024 revenue, gross margin, and year-end cash guidance. Recent Highlights Third quarter 2024 net revenues of $8
23-Oct-2024 3:05 PM CST - Business Wire KORU Medical Systems to Report Third Quarter 2024 Financial Results on November 13, 2024 KORU Medical Systems (NASDAQ: KRMD) (KORU Medical or the Company), a leading medical technology company focused on development, manufacturing, and commercialization of innovative and patient-centric large volume subcutaneous infusion solutions, today announced that the Company will report third quarter 2024 financial results on Wednesday, November 13, 2024. KORU Medicals management will host a conference call and webcast at 4:30 p.m. ET that day to discuss th

Disclaimer Privacy Contact

Copyright © 2001-2025, All rights reserved.
HotCandlestick.com, LLC

KRMD News
14-Jan-2025 3:06 PM CST - Business Wire KORU Medical Systems Reports Preliminary Fourth Quarter and Full Year 2024 Results; Achieves Record Full Year and Quarterly Revenues; Positive Cash Flow for the Fourth Quarter KORU Medical Systems (NASDAQ: KRMD) (KORU Medical or the Company), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and patient-centric large volume subcutaneous infusion solutions, today announced preliminary unaudited results for the fourth quarter and full year ended December 31, 2024. Financial Results (unaudited) Preliminary, unaudited fourth quarter 2024 net revenues expected to be $8.9 m
13-Jan-2025 7:00 AM CST - Business Wire KORU Medical Systems Reports Preliminary Fourth Quarter and Full Year 2024 Results; Achieves Record Full Year and Quarterly Revenues; Positive Cash Flow for the Fourth Quarter KORU Medical Systems (NASDAQ: KRMD) (KORU Medical or the Company), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and patient-centric large volume subcutaneous infusion solutions, today announced preliminary unaudited results for the fourth quarter and full year ended December 31, 2024. Financial Results (unaudited) Preliminary, unaudited fourth quarter 2024 net revenues expected to be $8.9 m
13-Nov-2024 3:05 PM CST - Business Wire KORU Medical Systems, Inc. Announces 2024 Q3 Financial Results, Third Consecutive Quarter of Double-Digit Growth; Raises Full Year 2024 Guidance KORU Medical Systems, Inc. (NASDAQ: KRMD) (KORU Medical or the Company), a leading medical technology company focused on development, manufacturing, and commercialization of innovative and patient-centric large volume subcutaneous infusion solutions, today reported financial results for the third quarter ended September 30, 2024, and raised full year 2024 revenue, gross margin, and year-end cash guidance. Recent Highlights Third quarter 2024 net revenues of $8
23-Oct-2024 3:05 PM CST - Business Wire KORU Medical Systems to Report Third Quarter 2024 Financial Results on November 13, 2024 KORU Medical Systems (NASDAQ: KRMD) (KORU Medical or the Company), a leading medical technology company focused on development, manufacturing, and commercialization of innovative and patient-centric large volume subcutaneous infusion solutions, today announced that the Company will report third quarter 2024 financial results on Wednesday, November 13, 2024. KORU Medicals management will host a conference call and webcast at 4:30 p.m. ET that day to discuss th